These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 9931135

  • 1. Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension.
    Mervaala EM, Müller DN, Park JK, Schmidt F, Löhn M, Breu V, Dragun D, Ganten D, Haller H, Luft FC.
    Hypertension; 1999 Jan; 33(1 Pt 2):389-95. PubMed ID: 9931135
    [Abstract] [Full Text] [Related]

  • 2. Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes.
    Mervaala E, Müller DN, Park JK, Dechend R, Schmidt F, Fiebeler A, Bieringer M, Breu V, Ganten D, Haller H, Luft FC.
    Hypertension; 2000 Jan; 35(1 Pt 2):360-6. PubMed ID: 10642325
    [Abstract] [Full Text] [Related]

  • 3. Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage.
    Muller DN, Mervaala EM, Schmidt F, Park JK, Dechend R, Genersch E, Breu V, Löffler BM, Ganten D, Schneider W, Haller H, Luft FC.
    Hypertension; 2000 Aug; 36(2):282-90. PubMed ID: 10948091
    [Abstract] [Full Text] [Related]

  • 4. Blood pressure-independent effects in rats with human renin and angiotensinogen genes.
    Mervaala E, Müller DN, Schmidt F, Park JK, Gross V, Bader M, Breu V, Ganten D, Haller H, Luft FC.
    Hypertension; 2000 Feb; 35(2):587-94. PubMed ID: 10679502
    [Abstract] [Full Text] [Related]

  • 5. NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats.
    Muller DN, Dechend R, Mervaala EM, Park JK, Schmidt F, Fiebeler A, Theuer J, Breu V, Ganten D, Haller H, Luft FC.
    Hypertension; 2000 Jan; 35(1 Pt 2):193-201. PubMed ID: 10642297
    [Abstract] [Full Text] [Related]

  • 6. Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects.
    Park JK, Müller DN, Mervaala EM, Dechend R, Fiebeler A, Schmidt F, Bieringer M, Schäfer O, Lindschau C, Schneider W, Ganten D, Luft FC, Haller H.
    Kidney Int; 2000 Oct; 58(4):1420-30. PubMed ID: 11012877
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin-converting enzyme inhibition and AT1 receptor blockade modify the pressure-natriuresis relationship by additive mechanisms in rats with human renin and angiotensinogen genes.
    Mervaala E, Dehmel B, Gross V, Lippoldt A, Bohlender J, Milia AF, Ganten D, Luft FC.
    J Am Soc Nephrol; 1999 Aug; 10(8):1669-80. PubMed ID: 10446934
    [Abstract] [Full Text] [Related]

  • 8. Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats.
    Pilz B, Shagdarsuren E, Wellner M, Fiebeler A, Dechend R, Gratze P, Meiners S, Feldman DL, Webb RL, Garrelds IM, Jan Danser AH, Luft FC, Müller DN.
    Hypertension; 2005 Sep; 46(3):569-76. PubMed ID: 16103264
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin II induced inflammation in the kidney and in the heart of double transgenic rats.
    Theuer J, Dechend R, Muller DN, Park JK, Fiebeler A, Barta P, Ganten D, Haller H, Dietz R, Luft FC.
    BMC Cardiovasc Disord; 2002 Sep; 2():3. PubMed ID: 11835691
    [Abstract] [Full Text] [Related]

  • 10. Pressure-natriuresis and -diuresis in transgenic rats harboring both human renin and human angiotensinogen genes.
    Dehmel B, Mervaala E, Lippoldt A, Gross V, Bohlender J, Ganten D, Luft FC.
    J Am Soc Nephrol; 1998 Dec; 9(12):2212-22. PubMed ID: 9848775
    [Abstract] [Full Text] [Related]

  • 11. Hypertension-induced end-organ damage : A new transgenic approach to an old problem.
    Luft FC, Mervaala E, Müller DN, Gross V, Schmidt F, Park JK, Schmitz C, Lippoldt A, Breu V, Dechend R, Dragun D, Schneider W, Ganten D, Haller H.
    Hypertension; 1999 Jan; 33(1 Pt 2):212-8. PubMed ID: 9931107
    [Abstract] [Full Text] [Related]

  • 12. Entacapone protects from angiotensin II-induced inflammation and renal injury.
    Helkamaa T, Finckenberg P, Louhelainen M, Merasto S, Rauhala P, Lapatto R, Cheng ZJ, Reenilä I, Männistö P, Müller DN, Luft FC, Mervaala EM.
    J Hypertens; 2003 Dec; 21(12):2353-63. PubMed ID: 14654757
    [Abstract] [Full Text] [Related]

  • 13. Rosuvastatin protects against angiotensin II-induced renal injury in a dose-dependent fashion.
    Park JK, Mervaala EM, Muller DN, Menne J, Fiebeler A, Luft FC, Haller H.
    J Hypertens; 2009 Mar; 27(3):599-605. PubMed ID: 19262227
    [Abstract] [Full Text] [Related]

  • 14. Wnt/β-catenin regulates blood pressure and kidney injury in rats.
    Xiao L, Xu B, Zhou L, Tan RJ, Zhou D, Fu H, Li A, Hou FF, Liu Y.
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun 01; 1865(6):1313-1322. PubMed ID: 30710617
    [Abstract] [Full Text] [Related]

  • 15. Endothelial dysfunction and xanthine oxidoreductase activity in rats with human renin and angiotensinogen genes.
    Mervaala EM, Cheng ZJ, Tikkanen I, Lapatto R, Nurminen K, Vapaatalo H, Müller DN, Fiebeler A, Ganten U, Ganten D, Luft FC.
    Hypertension; 2001 Feb 01; 37(2 Pt 2):414-8. PubMed ID: 11230310
    [Abstract] [Full Text] [Related]

  • 16. Inducible NOS inhibition, eicosapentaenoic acid supplementation, and angiotensin II-induced renal damage.
    Theuer J, Shagdarsuren E, Muller DN, Kaergel E, Honeck H, Park JK, Fiebeler A, Dechend R, Haller H, Luft FC, Schunck WH.
    Kidney Int; 2005 Jan 01; 67(1):248-58. PubMed ID: 15610248
    [Abstract] [Full Text] [Related]

  • 17. P450-dependent arachidonic acid metabolism and angiotensin II-induced renal damage.
    Kaergel E, Muller DN, Honeck H, Theuer J, Shagdarsuren E, Mullally A, Luft FC, Schunck WH.
    Hypertension; 2002 Sep 01; 40(3):273-9. PubMed ID: 12215466
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy.
    Müller DN, Mervaala EM, Dechend R, Fiebeler A, Park JK, Schmidt F, Theuer J, Breu V, Mackman N, Luther T, Schneider W, Gulba D, Ganten D, Haller H, Luft FC.
    Am J Pathol; 2000 Jul 01; 157(1):111-22. PubMed ID: 10880382
    [Abstract] [Full Text] [Related]

  • 19. Complement activation in angiotensin II-induced organ damage.
    Shagdarsuren E, Wellner M, Braesen JH, Park JK, Fiebeler A, Henke N, Dechend R, Gratze P, Luft FC, Muller DN.
    Circ Res; 2005 Sep 30; 97(7):716-24. PubMed ID: 16109917
    [Abstract] [Full Text] [Related]

  • 20. Endothelin-converting enzyme inhibition ameliorates angiotensin II-induced cardiac damage.
    Muller DN, Mullally A, Dechend R, Park JK, Fiebeler A, Pilz B, Löffler BM, Blum-Kaelin D, Masur S, Dehmlow H, Aebi JD, Haller H, Luft FC.
    Hypertension; 2002 Dec 30; 40(6):840-6. PubMed ID: 12468567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.